If You Already Switched To Organic Food, We Have Good News

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28 Bhawks #4862
334
If You Already Switched To Organic Food, We Have Good News For You

Bhawks, sounds like you are well versed on healthy food?

http://www.naturalblaze.com/2017/06/already-s...-news.html

According to a recent review of existing scientific data, foods with high levels of pesticides may compromise brain health and lower IQs.

The report, commissioned by the E.U. parliament to determine the safety of pesticides in food and the potential of organic alternatives, does not appear to be publicly available but has been viewed by multiple non-American outlets.

The American media has thus far largely failed to report on the ominous findings from the scientists working for the E.U.’s Scientific Foresight Unit, which was led by the Swedish University of Agricultural Scientists for this review.

As the Independent reported:

A report based on the review said a California study had found that children whose mothers had traces of organophosphate metabolites – the basis for many pesticides – during pregnancy were more likely to have “adverse mental development at two years of age, attention problems at three-and-a-half and five years, and poorer intellectual development at seven years”.
The outlet also reported that “Another study calculated that an estimated 13 million IQ points a year are lost as a result of pesticides, which represents a loss of approximately €125bn (£109bn) across the European Union,” though it was not specified exactly how that figure was calculated.

Nevertheless, the Independent noted, “the report suggested this figure was likely to be an under-estimation, as it failed to take into account the possible impact of pesticides on diseases like Parkinson’s, diabetes and some types of cancer.”

Unsurprisingly, advocates of pesticides were quick to deny the findings of the comprehensive review. Sarah Mukherjee, director of the Crop Protection Association — whose members include Monsanto, Dow Chemical, Syngenta, Bayer, and DuPont — argued that pesticides are approved by regulatory bodies, which apparently makes them safe.

“As the report itself acknowledges, they are only approved after extensive evaluation,” she said. “Crop protection products are amongst the most heavily regulated products in Europe, taking up to 12 years and costing over £200m to bring an active ingredient to market.”

However, the report acknowledged this, adding the caveat that despite “a comprehensive risk assessment before market release … important gaps remain.”

For example, in 2015 the E.U. dropped its plans to ban 31 pesticides amid pressure from U.S. officials. “ hese were dumped amid fears of a trade backlash stoked by an aggressive US lobby push, access to information documents obtained by Pesticides Action Network (PAN) Europe show,” the Guardian reported at the time.

Many of the health risks were known then. As the Guardian pointed out:

The result was that legislation planned for 2014 was kicked back until at least 2016, despite estimated health costs of €150bn per year in Europe from endocrine-related illnesses such as IQ loss, obesity and cryptorchidism – a condition affecting the genitals of baby boys.
This is far from the only example of industry interests seeking to exert influence over pesticide use.

Though Mukherjee asserted that European consumers are not exposed to levels of pesticides that can harm their health, the European body that sets limits on pesticide levels in food, the European Food Safety Authority, has its own conflicts of interest. Further, Mukherjee is hardly an unbiased source considering the first tab on the European Crop Protection Association’s homepage is titled “Why Pesticides,” and focuses on proving their legitimacy for massive agrochemical companies.

Further, as the Telegraph reported regarding the latest review, previous efforts to determine the safety of pesticides have fallen short:

‘Previous attempts to assess the risks have not taken proper account of epidemiological studies, which look at the health of whole populations, instead of just limiting themselves to scientific trials,’ [the report] suggests.

‘Of major concern, these risk assessments disregard evidence from epidemiological studies that show negative effects of low-level exposure to organophosphate insecticides on children’s cognitive development, despite the high costs of IQ losses to society,’ it states.
The report also expressed concern that current methods of analyzing the risks of pesticides are inadequate “at addressing mixed exposures, specifically for carcinogenic effects as well as endocrine-disrupting effects and neurotoxicity.”

“Furthermore,” they note, “there are concerns that test protocols lag behind independent science studies from independent science, are not fully considered and data gaps are accepted too readily.”

Still, there were some positive findings, as well. Lead author of the study, Assistant Professor Axel Mie, said:

Several practices in organic agriculture, in particular the low use of pesticides and antibiotics, offer benefits for human health.
The report found that organic food contains low levels of pesticides, meaning “potential risks to human health are largely avoided.”

Professor Ewa Rembiałkowska of Warsaw University added that organic crops have “lower cadmium content” than conventional crops. Cadmium is a known carcinogen that carries a variety of other health risks, as well.

The report also found a “link between organic food consumption and a decreased risk of allergic diseases, as well as potential benefits for overweight or obesity people.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Era for Small Cell Lung Cancer: Breakthroughs & Challenges

Updated Category News Views 39

Unpacking Small Cell Lung Cancer Progress These days, it feels like we're standing on the brink of something real big in the fight against small cell lung cancer. And I'm not talking about pie-in-the-sky ideas—there are some serious game changers coming down the pike, folks. You see, in the past, this aggressive cancer type was pretty much a death sentence. But thanks...

Continue Reading
Beta Bionics Lawsuit: What Investors Need to Know

Updated Category News Views 43

Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...

Continue Reading
Gildan Faces Investor Class Action After Stock Tumbles

Updated Category News Views 15

Shake-Up at Gildan: Investors Take Legal Action Gildan Activewear Inc. (NYSE:GIL) got themselves in hot water, folks. They've landed on the wrong side of an investor class action lawsuit after claims of shady business tactics sent their stock plummeting like a rock in June. We're talking about an 18.75% nosedive here. That's not just a slip—it's a fall worth wearing a...

Continue Reading
US State Dept. & IICA: Strengthening Disaster Response

Updated Category News Views 65

Bridging Borders to Tackle Disasters It seems like everyone and their grandma talks disaster aid, but when two giants like the US State Department's Bureau of Disaster and Humanitarian Response (DHR) and the Inter-American Institute for Cooperation on Agriculture (IICA) grab a coffee—real serious action is brewing. Why This Matters The partnership's not just talk. Let's...

Continue Reading
Ferrovial's 2026 Growth: North America Drives Success

Updated Category News Views 0

Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....

Continue Reading
Webull Faces Class Action: Deadline Looms Dec 2026

Updated Category News Views 25

Sinking Shares: The Webull Saga Unfolds Shady business practices can really make a stock take a nosedive, and that's what's happening with Webull Corporation, trading under NASDAQ:BULL. The alarm bells started ringing when the truth about their operations and ties to China came out. Turns out, what looked like a stable American fintech platform had its roots digging deep...

Continue Reading
Coulomb Solutions Powers Ahead with ReadyGrid Launch

Updated Category News Views 90

Breaking New Ground with ReadyGrid If you've been keeping an eye on the energy storage landscape, today's a big day. Coulomb Solutions, Inc. (CSI) is shaking things up by spinning off ReadyGrid, its own dedicated mobile energy storage powerhouse. The move is designed to tackle the pressing power challenges that have been nagging industries across the board, from...

Continue Reading
CTCA Tackles Trust Issues in $B-illion Card Market

Updated Category News Views 68

Gaps in a Booming Industry Trading cards might sound like kid stuff, but don’t be fooled—there's billions riding on paper and ink these days. Yet, a dark cloud hovers over the trading card scene, where questions of transparency and accountability loom large. Digital repacks and those dicey randomized packs have folks questioning what’s in the mix: Is it a safe bet...

Continue Reading
Tempo's Protein Max Meals: A High-Protein Revolution

Updated Category News Views 85

Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...

Continue Reading
Doximity Lawsuit: What Investors Need to Know Now

Updated Category News Views 56

Lawsuit Clouds Hang Over Doximity The courtroom isn't typically where you find stocks making headlines, but Doximity's recent plunge isn't just a market hiccup. After a rough patch, an alleged misstep lands them squarely under the legal microscope, and investors have questions. Tracing Doximity's Rocky Financial Reports First, let's rewind to November last year. Doximity...

Continue Reading

Top 5 Most Recently Viewed Articles

Deadline Approaching for Five9, Inc. Investors: Act Now

Updated Category News Views 125

Important Update for Five9, Inc. Investors Recent developments have brought Five9, Inc. into the spotlight as investors are reminded of a crucial deadline concerning a securities fraud class action lawsuit. If you have holdings in Five9, Inc. (NASDAQ: FIVN), understanding your rights and options is paramount, especially with the deadline for filing approaching. Investors...

Continue Reading
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook

Updated Category News Views 146

Overview of Bioretec Ltd's Financial Adjustments Bioretec Ltd announced major revisions to its previously reported first-half financial figures. The company acknowledged an adjustment related to its sales and distribution contract with Tri-State Biologics (TSB), a key aspect of its operational strategy. Understanding the TSB Distribution Agreement The initial TSB...

Continue Reading
Insights on Unemployment Trends and Federal Reserve Predictions

Updated Category News Views 252

Recent Analysis of U.S. Job Market Trends A recent report highlights a decline in unemployment rates within the U.S. labor market, suggesting possible changes in interest rate policies from the Federal Reserve. Economists are predicting that during the Fed's upcoming meeting, a rate cut of 0.25% may be on the table. Such a move could ease some economic pressures without...

Continue Reading
Protect Yourself from Ghost Tax Preparers This Tax Season

Updated Category News Views 111

Beware of Ghost Tax Preparers and Their Tactics The California Tax Education Council (CTEC) has issued a warning to taxpayers to remain vigilant as fraudulent ghost tax preparers continue to deceive unsuspecting clients. These tax preparers often promote themselves with promises of significant refunds and low fees, but they typically vanish soon after the tax deadline,...

Continue Reading
BTQ Technologies Enhances Leadership with Dr. Sean Kwak's Expertise

Updated Category News Views 322

BTQ Technologies Welcomes Dr. Sean Kwak as Strategic Advisor BTQ Technologies Corp. (CBOE CA: BTQ, FSE: NG, OTCQX: BTQQF), known for its focus on quantum technology, recently announced a significant addition to its leadership team. Dr. Sean Kwak, recognized as one of the foremost authorities in applied quantum technology in Korea, will step into the role of Strategic...

Continue Reading